|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM365273996 |
| 003 |
DE-627 |
| 005 |
20250305123501.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2023.109848
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1217.xml
|
| 035 |
|
|
|a (DE-627)NLM365273996
|
| 035 |
|
|
|a (NLM)38036277
|
| 035 |
|
|
|a (PII)S1521-6616(23)00612-5
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Kello, Nina
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Natural supplements in antiphospholipid syndrome
|b A case for further study
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 02.01.2024
|
| 500 |
|
|
|a Date Revised 10.04.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2023 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by thrombotic events and/or pregnancy complications in the presence of persistently positive antiphospholipid antibodies (aPL). Although long-term anticoagulation with vitamin K antagonists is considered standard of care, there is an unmet need for safe therapeutics as primary thromboprophylaxis or adjuncts to standard of care in APS. APS is driven by oxidative stress, procoagulant, proinflammatory and angiogenic pathways. For these reasons there has been an increased interest into the investigation of antithrombotic, anti-inflammatory and anti-oxidant properties of natural supplements in APS. The objective of this review is to summarize the mechanistic, epidemiologic and clinical evidence behind the use of natural supplements in APS, with a specific focus on vitamin D, omega-3 fatty acids, coenzyme Q10, gingerol, and isoquercetin. This review should serve as a compelling argument for the future study of natural supplements in APS
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Antiphospholipid syndrome
|
| 650 |
|
4 |
|a Coenzyme Q10
|
| 650 |
|
4 |
|a Gingerol
|
| 650 |
|
4 |
|a Isoquercetin
|
| 650 |
|
4 |
|a Natural supplements
|
| 650 |
|
4 |
|a Omega-3 fatty acids
|
| 650 |
|
4 |
|a Vitamin D
|
| 650 |
|
7 |
|a Anticoagulants
|2 NLM
|
| 650 |
|
7 |
|a Antibodies, Antiphospholipid
|2 NLM
|
| 700 |
1 |
|
|a Cho, Young Min
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 258(2024) vom: 15. Jan., Seite 109848
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnas
|
| 773 |
1 |
8 |
|g volume:258
|g year:2024
|g day:15
|g month:01
|g pages:109848
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2023.109848
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 258
|j 2024
|b 15
|c 01
|h 109848
|